Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2004-09-30
2010-10-26
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S009200, C424S184100, C424S234100, C424S248100
Reexamination Certificate
active
07820142
ABSTRACT:
The invention relates to immunogenic glycopeptides derived from pathogenic microorganisms, which can be used for immunization and diagnosing infections dye to such pathogenic microorganisms and also to method for the selection and preparation thereof.
REFERENCES:
patent: 7361348 (2008-04-01), Marchal et al.
patent: 96/23885 (1996-08-01), None
patent: 98/16646 (1998-04-01), None
patent: 98/29132 (1998-07-01), None
U.S. Appl. No. 12/034,926, filed Feb. 21, 2008, Marchal, et al.
U.S. Appl. No. 11/576,203, filed Mar. 28, 2007, Marchal et al.
Karen M. Dobos, et al., “Definition of the Full Extent of Glycosylation of the 45-Kilodalton Glycoprotein ofMycobacterium tuberculosis” Journal of Bacteriology, May 1996, pp. 2498-2506.
Henrikl Franzyk, et al., “Synthesis of aliphaticO-dimannosyl amino acid building blocks for solid-phase assembly of glycopeptide libraries”, J. Chem. Soc. Perkin Trans.1, (1995), pp. 2883-2898.
Felix Romain, et al., “Deglycosylation of the 45/47-Kilodalton Antigen Complex ofMycobacterium tuberculosisDecreases Its Capacity to Elicit in Vivo or in Vitro Cellular Immune Responses”, Infection and Immunity, Nov. 1999, pp. 5567-5572, vol. 67, No. 11.
Baleux Françoise
Marchal Gilles
Mulard Laurence
Pescher Pascale
Romain Felix
Institut Pasteur
Jones D L
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Immunogenic glycopeptides, screening, preparation and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic glycopeptides, screening, preparation and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic glycopeptides, screening, preparation and uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4180978